Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJm | Buenos Aires | ARS | Delayed | |
DJNJ3m | Buenos Aires | ARS | Delayed | |
DJNJ2m | Buenos Aires | ARS | Delayed | |
JNJ | NYSE | USD | Real-time | |
JNJ | CBOE Canada | CAD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
1JNJ | Milan | EUR | Real-time | |
JNJ | Frankfurt | EUR | Delayed | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJB34 | B3 | BRL | Delayed | |
JNJ | Vienna | EUR | Real-time | |
JNJ | Ukraine | UAH | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company’s Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON’S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company’s Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Mary C. Beckerle | 68 | 2015 | Independent Director |
Jennifer A. Doudna | 59 | 2018 | Independent Director |
Nadja Y. West | 62 | 2020 | Independent Director |
Marillyn A. Hewson | 69 | 2019 | Independent Director |
D. Scott Davis | 71 | 2014 | Independent Director |
A. Eugene Washington | 72 | 2012 | Independent Director |
Ian Edward Lamert Davis | 72 | 2010 | Independent Director |
Anne M. Mulcahy | 71 | 2009 | Lead Independent Director |
Joaquin Duato | 60 | 2011 | CEO & Chairman |
Mark B. McClellan | 59 | 2013 | Independent Director |
Mark Alan Weinberger | 61 | 2019 | Independent Director |
Darius E. Adamczyk | 57 | 2022 | Independent Director |
Hubert Joly | 64 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review